Real World Safety Data Indicate Drug-Drug Interactions with Paxlovid are Overstated
Apr 28th 2023 6:23am EDT
By Peter A. McCullough, MD, MPH Paxlovid (nirmatrelvir tablets; ritonavir tablets), is the only oral agent officially endorsed by HHS, NIH, CDC, FDA for the ambulatory treatment of COVID-19. It has been undermined by concerns regarding drug-drug interactions (DDI) as well as “rebound” or an extension of the illness with abbreviated use. My clinical impression […]
Promote it on DissentWatch!
- To advertise this post for $0.02 per visit send bitcoins to the address below
- The post will be promoted daily via social media & our "Featured News" display in multiple places
- You can add more anytime
- Ranking order in the Featured News box is based on the balance remaining
Received: 0 mBTC (0.00 USD)
Spent: 0 mBTC (0.00 USD)
Balance: 0 mBTC (0.00 USD)
The amounts above may be lagging behind. If you just sent a payment click below to get more up to date results and push the post to the "Featured News" box faster.